Study shows ePocrates helps reduce med errorsPhysicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented
Study shows ePocrates helps reduce med errors
Physicians who use the ePocrates qRx handheld clinical drug reference guide may be avoiding more than two million adverse drug events annually, according to data extrapolated from a study presented at the annual meeting of the American Medical Informatics Association. Investigators at Brigham and Women's Hospital in Boston conducted a seven-day online survey of ePocrates users during March. Some 870 physicians participated via e-mail; of these, 50% indicated that the qRx helped them avoid one or more adverse drug events per week. qRx was launched last November and is now used by more than 80,000 physicians, according to the company.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.